Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant TNFSF13 anticorps

Cet anticorps anti-TNFSF13 est un anticorps Souris Monoclonal détectant TNFSF13 dans ELISA, IP et Func. Adapté pour Souris.
N° du produit ABIN7566474

Aperçu rapide pour Recombinant TNFSF13 anticorps (ABIN7566474)

Antigène

Voir toutes TNFSF13 Anticorps
TNFSF13 (Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 88
  • 46
  • 29
  • 12
  • 6
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Souris

Hôte

  • 91
  • 24
  • 3
  • 2
  • 2
  • 1
Souris

Clonalité

  • 82
  • 41
Monoclonal

Conjugué

  • 67
  • 18
  • 6
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp TNFSF13 est non-conjugé

Application

  • 74
  • 37
  • 35
  • 33
  • 30
  • 29
  • 14
  • 13
  • 12
  • 10
  • 7
  • 6
  • 6
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
ELISA, Immunoprecipitation (IP), Functional Studies (Func)

Clone

Apry-1-1
  • Fonction

    anti-APRIL (mouse), mAb (rec.) (blocking) (Apry-1-1) (Fc LAEA-PG) (preservative free)

    Attributs du produit

    Recombinant Antibody. Recognizes mouse APRIL. Does not recognize human APRIL and mouse/human BAFF. Source: HEK293. Isotype: Mouse IgG2blambda. Immunogen: Mouse APRIL (aa 98-232). Applications: ELISA, FUNC (Blocking), IP. Inhibits the binding of mouse APRIL to BCMA and TACI. Works in vitro and in vivo. APRIL is a cytokine that belongs to the TNF superfamily and binds to TACI and BCMA. It is implicated in the regulation of tumor cell growth and is involved in monocyte/macrophage-mediated immunological processes. anti-APRIL (mouse), mAb (rec.) (Blocking) (Apry-1-1) (Fc LAEA-PG) (preservative free) is an antibody developed by antibody phage display technology using a human naive antibody gene library. These libraries consist of scFv (single chain fragment variable) composed of VH (variable domain of the human immunoglobulin heavy chain) and VL (variable domain of the human immunoglobulin light chain) connected by a polypeptide linker. The antibody fragments are displayed on the surface of filamentous bacteriophage (M13). This scFv was selected by affinity selection on antigen in a process termed panning. Multiple rounds of panning are performed to enrich for antigen-specific scFv-phage. Monoclonal antibodies are subsequently identified by screening after each round of selection. The selected monoclonal scFv is cloned into an appropriate vector containing a Fc mouse portion with mutations LAEA-PG and then produced in mammalian cells to generate an IgG like scFv-Fc (LAEA-PG) fusion protein. Mutations LAEA-PG inhibit binding to FcgammaRs and C1q while FcRn binding and Fc stability remain unaffected.

    APRIL is a cytokine that belongs to the TNF superfamily and binds to TACI and BCMA. It is implicated in the regulation of tumor cell growth and is involved in monocyte/macrophage-mediated immunological processes. anti-APRIL (mouse), mAb (rec.) (Blocking) (Apry-1-1) (Fc LAEA-PG) (preservative free) is an antibody developed by antibody phage display technology using a human naive antibody gene library. These libraries consist of scFv (single chain fragment variable) composed of VH (variable domain of the human immunoglobulin heavy chain) and VL (variable domain of the human immunoglobulin light chain) connected by a polypeptide linker. The antibody fragments are displayed on the surface of filamentous bacteriophage (M13). This scFv was selected by affinity selection on antigen in a process termed panning. Multiple rounds of panning are performed to enrich for antigen-specific scFv-phage. Monoclonal antibodies are subsequently identified by screening after each round of selection. The selected monoclonal scFv is cloned into an appropriate vector containing a Fc mouse portion with mutations LAEA-PG and then produced in mammalian cells to generate an IgG like scFv-Fc (LAEA-PG) fusion protein. Mutations LAEA-PG inhibit binding to FcgammaRs and C1q while FcRn binding and Fc stability remain unaffected.

    niveau d'endotoxine

    <0.001EU/μg purified protein (LAL-test, Lonza)

    Immunogène

    Mouse APRIL (aa 98-232).

    Isotype

    IgG2b lambda

    Biological Activity Comment

    Inhibits the binding of mouse APRIL to BCMA and TACI. Works in vitro and in vivo.
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    In PBS.

    Agent conservateur

    Without preservative

    Conseil sur la manipulation

    After opening, prepare aliquots and store at -20 °C. Avoid freeze/thaw cycles.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Stable for at least 1 month after receipt when stored at +4°C.

    Stable for at least 1 year after receipt when stored at -20°C.

  • Antigène

    TNFSF13 (Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13))

    Autre désignation

    APRIL

    UniProt

    Q9D777

    Pathways

    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response
Vous êtes ici:
Chat with us!